SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QDEL - Quidel more quick diagnosis
QDEL 24.35+14.3%Nov 21 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jeffbas who wrote (604)4/12/1997 1:29:00 AM
From: steve dietrich   of 1693
 
It seems to me that it might be more beneficial for the stock holders of a small company that is prospering and growing on its own, than to be swallowed up by a larger company. Especially when the small company has great growth potential. If the small company is stagnant, and management was not contributing to the enrichment of their company's owners, then I would agree that a poison pill provision would be only a self serving tool to keep their jobs. I don't believe that is the case with Quidel.

Also, I think that it is very common for the acquiring company, particularly in a hostile takeover to replace all or most of the top executives. Personally, I've been very satisfied with the way this company has run this company, in the time that I've been a shareholder. It's probably fortunate that Quidel had that 5 mil.come
in a short time ago, should give them capital for the expenses of the litigation, and probably be enough even if they were to have to
pay out some money in a settlement, or adverse decision in the suit.
As far as comparing one suit to another,Guess one can't really compare the results of any other suit to this one without knowing all the merits or lack of in each case.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext